Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer |
Prostate Cancer | Phase4 | Austria Belgium Canada Czechia France Germany Netherlands Spain Sweden United Kingdom United States View all |
NCT05803941 |
A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia |
Warm Autoimmune Hemolytic Anemia (wAIHA) | Phase3 | Argentina Australia China Germany Italy United Kingdom United States View all |
NCT05648968 |
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) |
Polymyalgia Rheumatica | Phase3 | Argentina Australia Belgium Brazil Colombia Czechia Denmark France Germany Hungary Israel Italy Japan Mexico Netherlands Poland South Africa Spain United Kingdom United States View all |
NCT06331312 |
Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France |
Breast Cancer | France | NCT05697146 | |
Revolade Tablets Specified Drug-use Survey |
Aplastic Anemia | Japan | NCT06287268 | |
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases |
Myeloid Diseases | Phase1 | France Germany Hong Kong Italy Singapore Spain United Kingdom United States View all |
NCT05552469 |
Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease |
Steroid-refractory Acute Graft Versus Host Disease | Phase4 | China | NCT06462469 |
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. |
Breast Cancer | Phase1, Phase2 | Australia Canada China France Germany Italy Netherlands Portugal Singapore South Korea Spain United Kingdom United States View all |
NCT06247995 |
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis |
Aortic Stenosis | Phase2 | Austria Belgium Canada Czechia Denmark France Germany Israel Italy Netherlands Portugal Spain Switzerland United Kingdom United States View all |
NCT05646381 |
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) |
Relapsing Multiple Sclerosis | Phase3 | Argentina Brazil Bulgaria Canada China Croatia Czechia Estonia France Germany Greece India Italy Japan Mexico Poland Portugal Puerto Rico Romania Slovakia Slovenia South Africa Spain Sweden Turkey (Türkiye) United Kingdom United States View all |
NCT05156281 |